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SUMMARY
1. We have examined whether an increase of renal vascular resistance is generally
accompanied by an inhibition of renin secretion. The effects of vasoconstriction
produced by angiotensin II (Ang II), arginine-vasopressin (AVP), and potassium
(KCl) depolarization on vascular resistance and on renin release from isolated rat
kidneys perfused at constant pressure of 100 mmHg were investigated.
2. Histological examination performed on some representative kidneys revealed
that the tubular lumina of all segments within the cortex were patent and the brush
borders of the proximal tubules were well preserved. The renal vasculature and the
juxtaglomerular region appeared to be morphologically intact. By immunocyto-
chemistry, renin-positive cells were found exclusively in the wall of the afferent
arterioles.
3. Basal flow rate through isolated kidneys was 14-5 + 2-0 ml min-1 (g kidney
weight (gkw))-l (mean+s.E.M., n = 10). Under control conditions renin secretory
rates were in the range of 30-40 (ng Ang I h-1) min-' gkw-1.
4. Ang II (100 pM) caused a decrease of renal flow rate to 42 + 2% of control which
was accompanied by a reduction of renin secretion rates by a factor of 4.
5. AVP (10 pM to 1 nM) reduced renal perfusate flow in a dose-dependent fashion
to a minimum of 25+3% of control. The vasoconstrictor effect of AVP was
paralleled by a concentration-dependent increase of renin secretory rates reaching a
factor of maximally 5 when AVP was used at a concentration of 1 nm. The
stimulatory effect of AVP on renin release could be mimicked by [deamino-Cys', D-
Arg8]-vasopressin (dDAVP), a vasopressin analogue with prevalent V2 receptor
agonistic properties. In the presence of dDAVP (100 nm, 1 /hM) renal flow rate
reversibly increased by 8 and 12% of control values, respectively.
6. Depolarizing concentrations of KCl (30 mM) decreased perfusate flow to
20+4% of control. The vasoconstrictor effect of KCl was paralleled by an increase
of the arterio-venous difference of perfusate renin activity to such an extent that the
rate of renin release remained unaltered.
7. Our findings suggest that there exists no general inverse relationship between
renal arteriolar resistance and renin secretion. Our study, moreover, does not support
MS 8960
H. SCHOLZ AND OTHERS
a functional role of potential operated calcium channels in the control of renin
secretion. Finally, we conclude that V2 receptors are present on juxtaglomerular
epithelioid cell membranes and mediate the stimulatory effect of AVP on renin
release from isolated rat kidneys.
INTRODUICTION
Renin secretion from renal juxtaglomerular epithelioid (JGE) cells is believed to be
under the inhibitory control of calcium (Churchill, 1988; for review see Kurtz, 1989).
This phenomenon, termed the calcium paradox of renin secretion, might seem
surprising at first sight because calcium normally initiates, facilitates or maintains
secretory activity in a variety of glands (Rasmussen, 1986a, b). From a teleological
point of view, however, the inhibitory effect of intracellular calcium on renin
secretion appears meaningful: by generating angiotensin II (Ang II), renin indirectly
induces calcium mobilization in vascular smooth muscle cells and thereby causes
vasoconstriction (Churchill & Churchill, 1982; Rasmussen, 1986a, b; Karaki &
Weiss, 1988). If renin secretion from JGE cells, which are metaplastically
transformed smooth muscle cells (Barajas, 1979; Taugner, Biihrle, Hackenthal,
Mannek & Nobling, 1984), was stimulated by a rise of cytosolic free calcium, the
enhanced formation of Ang II would lead via a positive feedback loop to unrestricted
vasoconstriction. An inhibitory effect of intracellular calcium on renin release would,
however, represent a very direct negative feedback control of renin secretion and of
vascular tone.
Under the assumption that both cell types, arteriolar vascular smooth muscle cells
and JGE cells, are equipped with the same membrane signal transduction systems
(Fray, Lush & Valentine, 1983; Hackenthal & Taugner, 1986) one could speculate
therefore that the rate of renin secretion and renal arteriolar resistance are generally
related in an inverse fashion. In fact, a number of observations exist that would
support such a relationship. In addition to Ang II, both the macula densa signal and
an increase of perfusion pressure cause renal arteriolar constriction and suppression
of renin secretion (cf. Kurtz, 1989). Conversely, a fall of perfusion pressure, hormones
activating adenylate cyclase, and calcium antagonists lead to renal arteriolar
dilatation and enhancement of renin secretion (cf. Kurtz, 1989).
Such a unifying concept linking the state of contraction of renal vascular smooth
muscle cells and renin secretion has not been systematically tested. It seemed
reasonable therefore to examine the relationship between renal arteriolar resistance,
reflecting state of contraction of vascular smooth muscle cells and renin secretion in
a preparation that allows both parameters to be monitored simultaneously. To this
end we have used the model of the isolated rat kidney perfused at constant pressure
(Schurek & Alt, 1981; cf. Scholz & Kurtz, 1990). To improve the functional
conservation of the preparation we have chosen a recirculatory system with a
perfusate containing red cells.
With this model we have examined the effects of three different vasoconstrictors,
namely Ang II, AVP, and potassium depolarization on renal vascular resistance and
renin secretion. Our results indicate that at the whole kidney level there exists no
general inverse relationship between vascular tone and renin secretion. The
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experimental variables chosen to produce renal vasoconstriction can inhibit, have no
effect, or stimulate renin secretion.
METHODS
MIale SIV strain rats (250-350 g body weight) having free access to commercial pellet chow and
tap water were used throughout. Kidney perfusion was performed according to the technique
developed by Schurek & Alt (1981). In brief: at the day of experiment the animals were
anaesthetized by intraperitoneal injection of 150 mg (kg body weight (Kgbw))-' of 5-ethyl-)1'-
methyl-propyl)-2-thio-barbituric acid (InactinR; Byk Gulden, Konstanz, Germany). The trachea
was cannulated with a polyethylene tube for artificial respiration with 25% 02 (Harvard respirator
75 strokes per minute, stroke volume 2 ml). Substitution for volume loss was performed by
intermittent injections of small volumes of physiological saline (about 0 5 ml) via a jugular vein
catheter. Following opening of the abdominal cavity the right kidney was exposed and placed in
a thermostatically controlled metal chamber which was fixed to a micropuncture table. After
intravenous heparin injection (2 U (g body weight (gbw))-'; LiqueminR, Roche, Basel, Switzerland)
and ligation of the large arteries branching off the abdominal aorta, a double-barrelled cannula was
inserted into the aorta and placed at the origin of the right renal artery. To avoid ischemia,
perfusion was started in situ with an initial flow rate of 8 ml min-'. Thereafter, the kidney was
isolated from the animal and perfused at constant pressure of 100 mmHg by means of a feedback
regulated peristaltic pump. Perfusion pressure was monitored through the inner part of the
perfusion cannula (Statham Transducer P 10 EZ). The basic perfusion medium, which was taken
from a thermostated (37 °C) reservoir (200-250 ml), consisted of a Krebs-Henseleit solution
containing (in mM) all physiologic amino acids in concentrations between 02 and 2-0, and 8-7
glucose, 0(3 pyruvate, 2-0 L-lactate, 1-0 cc-ketoglutarate, 1-0 L-malate and 6-0 urea. The perfusate
was supplemented with 2 g (100 ml)-' bovine serum albumin. Ampicillin (3 mg (100 ml)-') and
flucloxacilline (3 mg (100 ml)-') were used as antibiotics. Freshly washed human red blood cells
were added to the perfusion medium to a hematocrit of 10 + 2 %. Kidney perfusion was performed
in a recycling perfusion system by draining the renal venous effluent via a metal cannula back into
the reservoir. To improve the perfusion conditions the perfusate was continuously dialysed against
a 25-fold volume of the same composition but without erythrocytes and albumin. Oxygenation of
the dialysate was performed with a gas mixture containing 95% oxygen and 5% carbon dioxide.
Perfusate flow rate was obtained from the revolutions of the peristaltic pump which was calibrated
before and after each experiment. Renal flow rate and perfusion pressure were continuously
monitored by a potentiometric recorder (Kipp & Zonen, Delft, Netherlands). Stock solutions of the
drugs to be tested (see below) were dissolved in freshly drawn perfusate and infused into the arterial
limb of the perfusion circuit directly before the kidney (peristaltic pump 2132 MicroperpexR, LKB,
Bomma, Sweden) at 1 % of the rate of perfusate flow. For determination of perfusate renin activity
(pRA) aliquots (about 100 ,ul) were drawn from the arterial limb of the circulation and the renal
venous effluent, respectively. The samples were cooled on ice and stored at -20 °C until assayed
for renin activity.
Determination of renin activity
Aliquots of perfusate were incubated for 1 5 h at 37 °C with plasma of bilaterally nephrectomized
male rats as renin substrate (Rightsel, Okamura, Inagami, Pitcock, Taki, Brooks, Brown &
Muirhead, 1982). The generated angiotensin I was determined by radioimmunoassay (Medipro AG,
Teufen, Switzerland).
Renin release
Renin secretion from isolated perfused kidneys was calculated from differences between the
arterio-venous perfusate renin activities (AVDPRA) and the perfusion flow rate through the kidneys.
Histology and imniunocytochemistry
Fixation of the renal tissue. At the end of the experiments (after about 3-0 h) several kidneys were
perfused for 5 min with 2 5% paraformaldehyde, 0-1 % glutaraldehyde, 3 mM-MgCl2, and 0'5%
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picric acid, dissolved in 0 1 M-cacodylate buffer, pH 7-4, adjusted to 300 mosmol with sucrose.
Thereafter, the kidneys were flushed for 10 min by perfusion with iso-osmotic cacodylate buffer.
Histology and immunocytochemistry. One part of the kidneys was cut into small tissue blocks,
which were dehydrated in graded series of alcohols and embedded in LR-White resin (London
Resin, Basingstoke, UK) according to routine procedures. Semithin sections (1 aM) were made with
an ultramicrotome (Ultracut E, Reichert, Jung), stained with AzurlI/Methylene Blue and studied
by light microscopy (Polyvar, Reichert-Jung). The other part of the kidneys was used for
immunocytochemistry. To this end, tissue slices (about I mm thick) across the kidneys were frozen
in liquefied propane, cooled by liquid nitrogen and 5,am sections were cut with a cryostat at
temperatures of about -20 'C. Small tissue blocks (side length about 1 mm) were immersed for at
least 1 h in 2-3 M-sucrose, mounted in 2 3 M-sucrose on specimen holders and frozen as described
above. From these blocks 1 #tm thin sections were prepared at temperatures of about -90 'C with
an ultramicrotome, equipped with a cryo-chamber (Ultracut E, FC 4D, Reichert-Jung, Vienna,
Austria). All sections were transferred to chrome-alum gelatin coated slides, which were then
placed for at least 1 h in 0-05 M-NH4Cl in order to quench residual aldehyde function of the fixative.
Subsequently, the sections were incubated in normal swine serum, diluted 1:50 in phosphate
buffered saline (PBS) for 30 min, then in rabbit anti-rat renin serum (Takii, Figueiredo & Inagami,
1985), diluted 1: 1000 in PBS for 1 h. After washing in PBS the binding sites of the anti-renin serum
were visualized by incubation in a swine anti-rabbit serum, conjugated with fluorescein-
isothiocyanate (FITC; Dakopatts, Denmark). All incubations were made at room temperature.
Following a wash in PBS the sections were counterstained with a 01 % solution of Evans Blue
(Merck, Darmstadt, FRG) and mounted in glycerine gelatin (Glycergel DAKO, Dakopatts,
Denmark), containing 2 5 g (100 ml)-1 of 1,4-diazabiciclo[2,2,2,]octane (Sigma International) as
fading retardant. The sections were studied by epifluorescence (Polyvar, Reichert-Jung).
Photographs were taken on Kodak Technical Pan (light microscopy) and Kodak T-Max 400 ASA
(fluorescence).
Agents
Pyruvate was from Boehringer, Mannheim, Germany. Ampicillin and flucloxacillin were from
Beecham, Bern, Switzerland. Glutamate, urea, and oc-ketoglutarate were obtained from Merck,
Darmstadt, Germany. L-Malic acid and L-lactate as sodium salts were provided by Serva,
Heidelberg, Germany. L-Amino acids were from Braun/Melsungen, Germany (Aminoplasmal
paediatric free of carbon hydrate). Bovine serum albumin, angiotensin II, arginine-vasopressin,
and [deamino-Cys', D)Arg8]-vasopressin were purchased from Sigma International. D-Sucrose was
from Fluka, Buchs, Switzerland. The RIA kit for determination of Ang I was obtained from
Medipro AG, Teufen, Switzerland.
Statistics
Levels of significance were calculated by using Student's t test. P < 005 was considered
significant.
RESULTS
The kidneys were usually perfused in vitro for 3 h. Since, to our knowledge, the
isolated rat kidney (IPRK) perfused with a medium containing red cells has not yet
been used as an experimental model to study renin secretion, we have characterized
this preparation also by histological examination. To perceive possible morphological
alterations, in particular, of the vasculature and the juxtaglomerular regions, some
kidneys were fixed after 3 h of perfusion. They were processed for histological
examination and for renin immunohistochemistry.
General appearance. The tubular lumina of all segments within the cortex (Fig. 1A)
and the medulla were patent. Occasionally, some cell debris and shedded necrotic
cells were present in the lumina. Epithelial cells were not swollen. The basal
infoldings in most segments were readily discernible, due to a regular, slight widening
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of the intercellular spaces. This might indicate a small degree of cellular shrinkage.
The interstitial spaces in all zones contained largely open capillaries.
Renal corpuscles. The glomerular tuft appeared to be unaltered by the in vitro
conditions. The capillaries were patent. Occasionally, some cell debris was present in
their lumina but did not obstruct them. The structure of podocytes and Bowman's
capsule revealed the same aspect as in the kidneys fixed by vascular perfusion in vivo
(Fig.lA).
Tubules. The brush border was well preserved in all three segments of the proximal
tubule (Fig. IA). In SI segments vacuoles of rather uniform size, belonging to the
vacuolar apparatus, were well evident at the base of the brush border. The cytoplasm
of S2 segments appeared to be rather dense. In the apical cytoplasm of S2 segments
great accumulations of endocytotic vesicles were present, protruding the apical cell
pole into the lumen (Fig. 1A). These vesicles most probably indicate uptake of
proteins from the tubular fluid. All segments situated in the medullary zones (not
shown) appeared to be well preserved. In particular, no cellular swelling was
apparent. The same applies to the distal segments in the cortex. The apical
cytoplasm of distal convoluted cells showed some small cytoplasmic protrusions.
Occasionally, some cells in the connecting tubule and collecting duct were vacuolated
and shed into the lumen.
Vasculature. Endothelial cells in peritubular capillaries (Fig. 1A), in arteries and
arterioles appeared to be intact (Fig. 1 C). The smooth muscle cells of the arterial
walls were discernible and revealed no vacuoles.
Juxtaglomerular apparatus (JGA). The intercellular spaces between the macula
densa cells were dilated, as usually found in rat kidneys, in which the tubulo-
glomerular feedback had not been inhibited by, for instance, furosemide. In
proximity of the vascular pole and among the smooth muscle cells along the afferent
arteriole, granular cells were discernible (Fig. 1 C). By immunocytochemistry, using
a polyclonal antibody against rat kidney renin (Takii et al. 1985), the presence of
renin within these cells is evident by the bright fluorescence. Other structures of the
kidney than the granular cells did not bind to this antibody (Fig. 1B).
The time courses ofperfusion flow rate, arterial and venous perfusate renin activity
(pRA) and renin release from IPRKs run under control conditions are shown
in Fig. 2. Perfusate flow through isolated kidneys was 14-5 + 2-0 ml min-' gkw-'
(mean + S.E.M., n = 10) under control conditions. Renal flow rate remained constant
during the first 2 h of perfusion. From then on, renal perfusate flow continuously
decreased reaching a value of 12-5 + 2-5 ml min-' gkw-' at 3 h after the onset of
perfusion. Arterial perfusate renin activity (APRA) as measured in aliquots taken
from the arterial limb of the perfusion circuit, steadily increased from 3+1 to
18 + 3 ng Ang I h-' ml-' gkw-1 (n = 6) during the 3 h perfusion periods (Fig. 2). The
increase ofAPRA was accompanied by a parallel rise of the renin activity determined
in the renal venous effluent (VpRa) which increased from 5+1 at the beginning to
25 + 3 ng Ang I h-1 ml-' gkw-1 at the end of perfusion (n = 6). Consequently, the
arterio-venous difference of perfusate renin activity (AVDpRA) remained almost
constant during the course of the experiments (Fig. 2). Only towards the end of the
perfusion periods was an increase of A VDpRA usually observed. The time courses of
renin secretion rates (RSR) which were calculated from the A VDpRA and the renal
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Fig. 1. For legend see facing page.
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aaA
Fig. 1. A, semithin section of LR-White embedded renal cortex from a kidney perfused
in vitro for 3 h. The tubular lumina as well as the peritubular capillaries are open. The
brush border in SI and S2 segments of the proximal tubule is rather well preserved. Note
the accumulation of vesicles in the apical pole of S2 cells. Some cell debris is visible in a
glomerular capillary. In some cells of the distal tubule (D) small cytoplasmic protrusions
are present. G, glomerulus; ea, efferent arteriole; aa, afferent arteriole; T, thick ascending
limb of Henle's loop. Scale bar, 20 ,um. B, cryostat section; FITC-immunofluorescence,
revealing binding sites in the tissue to antibodies against renin. Only granular cells in the
afferent arterioles (aa) display a bright fluorescence. The granules in the cells are readily
visible. A, cortical radial artery; D, distal tubule; G, glomerulus; ea, efferent arteriole; St
and S2, segments of the proximal tubule; T, thick ascending limb of Henle's loop. Scale
bar, 20 ,am. C, semithin section of LR-White embedded tissue; juxtaglomerular
apparatus. The cell plaque of the macula densa (MD) is obvious within the TAL by the
dilated intercellular spaces. The endothelial cells (arrow heads) in the afferent arteriole
(aa) are flat; granular cells (arrows) among the smooth muscle cells are evident by their
granular content; EGM, extraglomerular mesangium. Scale bar, 20 ,um.
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Fig. 2. Time courses of perfusate flow rates, arterial (A) and venous (A) perfusate renin
activities (pRA), and renin secretion rates (RSR) of isolated rat kidneys perfused for 3 h
under control conditions. As can be seen, basal flow rates were in the range of
14-5 ml min-' gkw-I during the first 2 h and decreased to values of 12-5 ml min-' gkw-'
towards the end of perfusion. Arterio-venous differences of pRA also remained nearly
constant for a 2-5 h perfusion period. Renin secretion rates displayed a slow and almost
linear increase over the courses of the experiments. Values are means+S.E.M. (n = l0).
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perfusate flow rates displayed a slight and almost linear increase ranging from 31 + 7
at 30 min to 45 + 8 (ng Ang I h-') min-' gkw-1 at 180 min after perfusion start (Fig.
2). Since the arterio-venous difference of pRA is the sum of intrarenal renin
inactivation and intrarenal renin release, we have examined a possible inactivation
of renin within the IPRK. To this end systemic (arterial) and effluent (venous) pRA
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Fig. 3. Effect of the addition of exogenous rat renin to the perfusion medium on arterial
(A) and venous (A) perfusate renin activity (pRA). A bolus of exogenous rat renin given
at about 80 min after the onset of perfusion (arrow) increased arterial and venous pRA
to the same extent thus leaving the arterio-venous difference ofpRA unchanged (n = 5).
This suggests that under our experimental conditions no significant inactivation of renin
occurred during the passage through the isolated perfused rat kidney. Values are
means +S.E.M. (n = 5).
were monitored before and after the addition of exogenous rat renin to the perfusate.
A pool of perfusate with high renin activity was produced by pre-incubating 1 ml of
perfusate with isolated rat JGE cells (Kurtz, Pfeilschifter, Hutter, Biihrle, Nobiling
Taugner, Hackenthal & Bauer, 1986). As can be seen from Fig. 3, venous pRA rose
to the same extent after the addition of renin as arterial pRA did. This suggests that
under our experimental conditions no significant inactivation ofrenin occurred during
the passage through the isolated kidney.
We then examined the effects of angiotensin II (Ang II), arginine-vasopressin
(AVP), and of high extracellular potassium (KCl; 29 + 2 mM) on perfusate flow rates,
arterio-venous differences ofpRA and on the resulting renin secretion rates. Ang II
(100 pM) decreased renal perfusate flow rates to 42 + 2% of the control values
(mean + S.E.M., n = 5; Fig. 4). The delay of the vasoconstrictor effect of Ang II was
less than 15 s. After removal of Ang II flow rates returned to control values within
6 min. Ang II-induced renal vasoconstriction was accompanied by a significant
reduction of the arterio-venous differences of pRA (Fig. 4). In presence of Ang II
AVDPRA was decreased to 1-4 + 0-3 as compared to 2-2 + 0-3 ng Ang I h-1 ml-' gkw-'
during the control periods (Fig. 4). In consequence, the fall of flow rates caused
by Ang II was paralleled by a reduction of renin secretory rates by a factor of 4
(Fig. 4).
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AVP (1 nM) also reversibly decreased renal perfusate flow to 25+3% of control
(n = 5; Fig. 5). After removal of AVP perfusate flow reached control values with a
delay of approximately 13 min. The vasoconstrictor effect of AVP, moreover, was
dependent upon the concentration used. AVP at a concentration of 10 pM decreased
renal flow rate to 95 +0'5% and in presence of 100 pM-AVP perfusate flow was
Ang 11(100 pM)
14
3: 8
0
E 6
E 4
2 mi
Fig. 4. Effect of angiotensin II (Ang II) on perfusate flow rates, arterio-venous differences
of perfusate renin activity (AVDPRA) and renin secretory rates (RSR) of isolated rat
kidneys. Values are means + SE.M_, n = 5. * Significantly different from control. Student's
ttest (P < O'05).
reduced to 80+1 % of control values (n = 3; Fig. 6). AVP (1 nM)-induced increase of
renal vascular tone was accompanied by an approximately 15-fold increase of the
AVDPRA (Fig. 5). As a result renin secretion from isolated kidneys increased
from 20+±5 (ng Ang I h-1) min-1 gkw'l during control periods to maximally
100±5 (ng Ang I h'l) min-1 gkw-1 during AVP (1 nM; Fig. 5). As illustrated in Fig.
6, the stimulatory effect of AVP on renin release was concentration dependent.
When used at 10 pMv, AVP caused an approximately 50 % increase of renin secretory
rates; at a concentration of 100 pM., AVP stimulated renin release from isolated rat
kidneys by a factor of nearly 2'S. Renin secretion rates returned to control values in
parallel with the recovery of renal vascular resistance. [deamino-Cys1,D-Arg8]-
Vasopressin (dDAVP), a vasopressin analogue with prevalent V2 receptor agonistic
properties (Weingartner, Gold, Ballenger, Smallberg, Summers, Rubinow, Post &
Goodwin, 1981), increased renal flow rate by 8+0'5% and 12+1 % of control, when
used at concentrations of 100 nM and 1 ,UM, respectively (n = 3; Fig. 7). In addition,
dDAVP stimulated renin secretion from isolated rat kidneys in a dose-dependent
fashion. When used at 100 nM, dDAVP caused an approximately 2'S-fold rise of renin
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Fig. 5. Effect of arginine vasopressin (AVP) on renal flow rates and renin secretion from
isolated perfused rat kidneys. AVP (1 nM) decreased perfusate flow rates to 25+3% of
control (n = 5). At the same time, a 15-fold increase of the arterio-venous difference of
perfusate renin activity (AVDPRA) was observed. As a result, AVP at a concentration of
1 nm stimulated renin release (RSR) from isolated kidneys by a factor of about 5. Values
are means+ S.E.M., n = 5. *Significantly different from control. Student's t test (P <
005).
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Fig. 6. Dose-response traces of arginine vasopressin (AVP). AVP used at concentrations
of 10 pM, 100 pm, and 1 nm decreased renal flow rates to 95 + 0 5, 80 + 1 and 25 + 3% of
control, respectively. AVP-induced renal vasoconstriction was paralleled by a con-
centration-dependent rise of renin secretory rates (RSR). Values are means+S.E.M.,
n = 3. * Significantly different from control. Student's t test. (P < 0 05).
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Fig. 7. Effect of [deamino-Cys',D-Arg8]-vasopressin (dDAVP), a vasopressin analogue
with prevalent V2 receptor agonistic properties, on renal flow rate and renin secretion.
dDAVP used at concentrations of 100 nm and 1 ,UM increased renal flow rate by 8+0-5 and
12 + 1 %, respectively. Renal vasodilatation caused by dDAVP was associated with a
dose-dependent stimulation of renin release (RSR) from isolated rat kidneys. AVP (1 nM)
was taken as control. Values are means+ S.E.M., n = 3. *Significantly different from
control. Student's t test (P < 005).
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Fig. 8. Effect of the addition of depolarizing concentrations of potassium chloride (KCl)
to the perfusate. KCI led to a fall of flow rate to 20 + 4% of control (n = 5). KCl-induced
increase of renal vasotone was accompanied by a uniform rise of the arterio-venous
difference of perfusate renin activity (AVDpRA). In consequence, renin secretion rates
(RSR) remained unchanged in presence of depolarizing concentrations of KCl. Values are
means+ S.E.M., n = 5. * Significantly different from control. Student's t test (P < 0-05).
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secretory rates; at a concentration of 1 /,M, dDAVP stimulated renin release by a
factor of about 3 (Fig. 7).
Depolarizing concentrations of KCl (30 mm, final concentration) led to a reduction
of perfusate flow rates to 20 + 4% of the control values (n = 5; Fig. 8). The delay
of the vasoconstrictor effect of KCl was usually less than 15 s. Arterio-venous
differences of pRA increased in the presence of KCl (30 mM) from 2 5 + 1 0 ng Ang I
h-1 ml-1 gkw-1 during control periods to maximally 9 5 + 2 5 ng Ang I h-1 ml-' gkw-1
(Fig. 8). This increase was inversely correlated to the drop of flow rate induced by
KCl. As a consequence renin secretion rates did not significantly change in the
presence of depolarizing concentrations of potassium (Fig. 8). Since osmolality of the
perfusate was increased during administration of KCl appropriate controls were
made by the addition of 25 mM-NaCl or 50 mM-sucrose to the perfusate. Addition of
both, NaCl or sucrose, to the perfusion medium did not alter renin secretion rates
(not shown).
DISCUSSION
Our study suggests that the isolated rat kidney perfused at constant pressure in a
recirculatory system containing erythrocytes is a suitable model to study the
regulation of renal vascular resistance and of renin secretion in parallel. The
morphology of the renal vasculature and of the juxtaglomerular region is well
preserved in this preparation at least during 4 h of perfusion (Fig. 1). We think that
the low basal secretion rates of renin also suggest a preserved function of the
juxtaglomerular region. For comparison, basal renin secretion rates from IPRK in
single pass experiments were reported to be in the range of 500-1000 (ng Ang I
h-1) min-1 (Konrad, Hofbauer, Werner & Gross, 1978; Nobiling, Miinter, Biihrle &
Hackenthal, 1990). These values are higher by a factor of about 10-30 than those
found in this study.
Since there is no appreciable degradation of renin activity during passage through
the IPRK (Fig. 3), renin secretion rates can be calculated directly from the values
of the arterio-venous differences of pRA and the renal flow rates.
Our findings that Ang II, AVP, and potassium reproducibly and reversibly
increased renal vascular resistance fits well with the results produced by others
(Cooper, Shaffer & Malik, 1985; Loutzenhiser, Hayashi & Epstein, 1989). They
confirm the concept that a rise of cytosolic calcium brought about by mobilization
of calcium from intracellular stores or by enhancement of calcium entry due to the
activation of receptor and potential operated calcium channels is a key signal also for
the contraction of renal vascular smooth muscle cells (Cooper et al. 1985; Carmines
& Navar, 1989). The vasoconstrictor effect of Ang II was paralleled by a decrease of
the arterio-venous difference of perfusate renin activity (pRA; Fig. 4). This
observation is in harmony with previous studies showing that Ang II inhibits renin
secretion in vivo and in vitro (Keeton & Campbell, 1981). In the presence of high
potassium the arterio-venous differences of pRA increased in relation to the increase
of vascular resistance (Fig. 8). In consequence, the renin secretion rate was not
influenced by potassium. The increase of perfusate osmolality as a possible
explanation for the lacking effect of K on renin secretion appears unlikely, because
the addition of NaCl or sucrose in equiosmolar concentrations did not affect renin
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secretion. Our finding that potassium did not alter renin secretion contrasts with
studies reporting that depolarizing concentrations of potassium inhibit renin
secretion from renal slices (Churchill & Churchill, 1982) and also from isolated rat
kidneys but only if extracellular calcium concentrations are in the supraphysiological
range (Fray, 1978). High concentrations of potassium (50 mM) have been reported to
stimulate renin secretion from IPRK if extracellular calcium is low (Fray, 1980).
There are two possible explanations for our findings with respect to the existence
of potential operated calcium channels (POCC) in JGE cells. First, if we assume that
JGE cells have in fact POCC, then we have to infer from our results, that a rise of
calcium in JGIE cells through POCC itself is not sufficient to block renin secretion.
The second possible explanation for our findings is that renal JGE cells do not possess
POCC. This conclusion would be in concordance with our previous in vitro studies
providing no evidence for the existence of those channels in JGE cells (Kurtz, Skott,
Chegini & Penner, 1990).
Another unexpected finding in our study was that AVP in a concentration range
of 10 pM to 1 nm stimulated renin release from isolated perfused rat kidneys in a dose-
dependent fashion (Figs 5 and 6). In vivo effects of AVP on renin release are
controversial. In several studies vasopressin has been found to decrease renin
secretion in vivo (cf. Keeton & Campbell, 1981; Schwartz & Reid, 1986). However, it
has also been shown that the non-osmotic release of AVP is associated with a
concomitant activation of the renin-angiotensin system (Ishikawa & Schrier, 1984;
Riegger, Liebau. Bauer & Kochsiek, 1985). From in vitro studies, using isolated
kidneys perfused without red cells, it has been reported that vasopressin did not
affect basal renin secretion but attenuated the stimulatory effect of /8-adrenergic
agonists on renin release (Vandongen, 1975; Konrads et al. 1978). At the cellular
level, vasopressin is considered to act primarily via two distinct receptor types
classified by their different second messengers (Michell, Kirk & Billah, 1979). The V1
receptor acts via phosphatidylinositol hydrolysis thus increasing cellular inositol-
triphosphate (IP3) and diacylglycerol (DAG) content (Michell et al. 1979). The
rise of cellular IP3 levels leads to calcium mobilization from intracellular stores
whereas DAG is a potent activator of protein kinase C (PKC) (Castagna, Takai,
Kaibuchi, Sano, Kikkawa & Nishizuka, 1982; Berridge, 1984). Both events, cellular
calcium mobilization and activation of PKC, are thought to act in concert in
mediating the vasoconstrictor effect of vasopressin (Caramelo, Okada, Tsai &
Schrier, 1989). Furthermore, the so-called V2 receptor which is mainly located in the
kidneys (late distal tubule, collecting duct) is coupled to adenylate cyclase and acts
bv increasing cellular cyclic AMP levels (cf. Morel, Imbert-Teboul & Chabardes,
1987). The antidiuretic effect of AVP is mediated by the V2 receptor (cf. Morel et al.
1987). At the cellular level, the concentration-dependent increase of renin secretion
observed in this study could have been due to either direct action ofAVP on the JGE
cell membrane or due to some indirect e.g. tubular effect of AVP. In fact, it has been
reported that AVP at micromolar concentrations inhibits renin release from cultures
of isolated JGE cells (Kurtz et al. 1986). Moreover, inhibition of renin secretion from
isolated JGE cells by AVP was associated with increased phosphatidylinositol
breakdown indicating that the inhibitory effect of AVP in cultured JGE cells was
most likely mediated by the V1 receptor (Kurtz et al. 1986). This conclusion is in
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harmony with results obtained by microelectrode studies on JGE cells. There it has
been found that AVP at concentrations of 1 /UM caused a marked depolarization of
JGE cells as it was seen also with other calcium mobilizing hormones (Biihrle, Scholz,
Hackenthal, Nobiling & Taugner, 1986). Since the signal transduction mechanism of
the Vi receptor is probably similar to that of the Ang II receptor (Kurtz et al. 1986)
it appears rather unlikely that the stimulatory effect of AVP on renin release from
the IPRK was mediated via V1 receptors. A much better candidate for stimulation
of renin secretion would be V2 receptors coupled to adenylate cyclase, because a rise
of the cellular cyclic AMP levels is a stimulatory signal for renin release from JGE
cells (cf. Kurtz. 1989). Our finding that dDAVP, a vasopressin analogue acting
predominantly on V2 receptors (WVeingartner et al. 1981), significantly decreased
renal arteriolar resistance and at the same time stimulated renin secretion from
isolated rat kidneys (Fig. 7) suggests that V2 receptors are not only located on renal
tubular cells. but they also occur in the renal vasculature. This conclusion is in
concordance with recent studies showing that both, selective V2 receptor agonists
and AVP during V1 receptor blockade, elicit V2-like haemodynamic effects
(peripheral vasodilatation, increase of heart rate and cardiac output) in conscious
dogs (Liard, 1989, 1990) and also in rats (Walker, 1986). Moreover, it has been
shown recently that vasopressin-induced forearm vasodilatation in humans is
mediated by vascular V2 receptors (Hirsch, Dzau, Majzoub & Creager, 1989). These
findings suggest that beside their location on renal tubular cells, V2-like receptors
may also occur in the vasculature, e.g. on vascular smooth muscle cells. Since JGE
cells are metaplastically transformed smooth muscle cells (Barajas, 1979; Taugner
et al. 1984), one may infer that V2 receptors could also occur on JGE cells and thus
mediate the stimulatory effect of AVP on renin secretion from isolated perfused rat
kidneys. Possible reasons why vasopressin has been found in previous studies to
decrease rather than to stimulate renin secretion could be that AVP in those studies
has mostly been used in the micromolar concentration range (Schwartz & Reid,
1986). At micromolar concentrations which are higher by a factor of 1000 than we
have used in our study, however, AVP has been shown to inhibit renin release from
isolated JGE cells via the V1 receptor (Kurtz et al. 1986). A further possibility could
be that V2 receptor degradation usually occurs very rapidly under in vitro
conditions. Therefore. our finding that AVP increased renin secretion by a V2
receptor dependent signal transduction mechanism suggests that V2 receptors are
well preserved in the isolated rat kidney perfused with a medium containing red cells.
Taken together, our study suggests that there is no general link between renal
arteriolar resistance and inhibition of renin secretion.
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